Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Neoplasms
  • Etoposide
  • Ifosfamide
  • Neuroectodermal Tumors, Primitive
  • Sarcoma, Ewing

abstract

  • The addition of ifosfamide and etoposide to a standard regimen does not affect the outcome for patients with metastatic disease, but it significantly improves the outcome for patients with nonmetastatic Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of bone.

publication date

  • February 20, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa020890

PubMed ID

  • 12594313

Additional Document Info

start page

  • 694

end page

  • 701

volume

  • 348

number

  • 8